Funding for this research was provided by:
National Health and Medical Research Council (1107126, 1196755, 1196749, 1194783, 1116955)
Cancer Council Victoria
Victorian Cancer Agency
Howard Hughes Medical Institute (55008729)
Received: 1 October 2020
Accepted: 4 June 2021
First Online: 23 June 2021
: Written informed consent was obtained from all patients under an approved Human Research Ethics Committee protocol from the Peter MacCallum Cancer Centre (PMCC: 11/105) with all methods performed in accordance with the Helsinki Declaration and relevant ethical guidelines and regulations of the Australian National Health and Medical Research Council.
: Not applicable.
: S.J.D has been a member of an advisory board for Astra Zeneca and Inivata. S.J.D has received research funding from Genentech. S.J.D and M.A.D have received research funding from CTx CRC. M.A.D. has been a member of advisory boards for CTx CRC, Storm Therapeutics, Celgene and Cambridge Epigenetix.